Return to study ST000593 main page

Download data matrix(PGD2 and other lipid mediator changes in mouse adipose associated with administration of an oral inhibitor of H-PGDS (HQL-79) Reversed phase POSITIVE ION MODE)

AnalysisSamplesFactorsUnits
Reversed phase POSITIVE ION MODEHQL_01Treatment:HQL-79pmol/g
Reversed phase POSITIVE ION MODEHQL_02Treatment:HQL-79pmol/g
Reversed phase POSITIVE ION MODEHQL_03Treatment:HQL-79pmol/g
Reversed phase POSITIVE ION MODEHQL_04Treatment:HQL-79pmol/g
Reversed phase POSITIVE ION MODEHQL_05Treatment:HQL-79pmol/g
Reversed phase POSITIVE ION MODEHQL_06Treatment:HQL-79pmol/g
Reversed phase POSITIVE ION MODEHQL_07Treatment:HQL-79pmol/g
Reversed phase POSITIVE ION MODEHQL_08Treatment:HQL-79pmol/g
Reversed phase POSITIVE ION MODEVeh_01Treatment:Vehiclepmol/g
Reversed phase POSITIVE ION MODEVeh_02Treatment:Vehiclepmol/g
Reversed phase POSITIVE ION MODEVeh_03Treatment:Vehiclepmol/g
Reversed phase POSITIVE ION MODEVeh_04Treatment:Vehiclepmol/g
Reversed phase POSITIVE ION MODEVeh_05Treatment:Vehiclepmol/g
Reversed phase POSITIVE ION MODEVeh_06Treatment:Vehiclepmol/g
Reversed phase POSITIVE ION MODEVeh_07Treatment:Vehiclepmol/g
Reversed phase POSITIVE ION MODEVeh_08Treatment:Vehiclepmol/g
  logo